Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

Donald Trump calls it “big” and “beautiful.” He flashes it like ILL-gotten gain at campaign rallies, the massive, ...

Surveillance data collected over a 10-year period showed a substantial increase in the incidence of invasive GAS disease among US patients across 10 states.

The World Health Organization has added the variant, known formally as XFG, to its monitoring list. A dry, irritated throat ...

A South Carolina beach town once nicknamed “Dirty Myrtle” because of its rowdy nightclubs and strip joints has become a ...